• Aucun résultat trouvé

Genetics: Prostate cancer

N/A
N/A
Protected

Academic year: 2022

Partager "Genetics: Prostate cancer"

Copied!
1
0
0

Texte intégral

(1)

710

Canadian Family PhysicianLe Médecin de famille canadien Vol 55: july • juillet 2009

Genetics

Genetics

Prostate cancer

Sean M. Blaine

MD

Christina Honeywell

MSc

Judith Allanson

MD

Carol Cremin

MSc

Heather Dorman

MSc

Clare A. Gibbons

MS

Wendy S. Meschino

MD

Joanne Permaul June C. Carroll

MD

T

he genetic basis of prostate cancer is complex and there are likely many different genes that modify risk. A major prostate cancer susceptibility gene has not yet been identified, but areas in the genome that might harbour prostate cancer–related genes are being investigated. Several studies show that 3 adjacent regions on chromosome 8 are asso- ciated with increased prostate cancer risk.1

Bottom line. None of the candidate genes is individually associated with a high risk of pros- tate cancer predisposition. It is likely that multiple genes contribute to the risk. At present, clinical genetic testing for inherited prostate cancer sus- ceptibility is not available.

The complete Gene Messenger—Prostate Cancer by the GenetiKit research team is available on CFPlus.* Past Gene Messenger articles can be accessed on-line at www.cfp.ca. On the home page, click on Collections in the left-hand menu, then click on Genetics.

Competing interests None declared

The GenetiKit research team, a group of family physicians, genetic counselors and geneticists, designed the Gene Messenger series to pro- vide practical information to help family physicians and their patients make informed choices about rapidly emerging genetic discoveries. The series is a collection of up-to-date, definitive, short reviews on genetics topics that have made headlines, and offers recommendations regard- ing referral for genetic services or testing.

Acknowledgment

Funding was provided by the Canadian Institutes of Health Research.

Reference

1. Gudmundsson J, Sulem P, Manolescu A, Amundadottir LT, Gudbjartsson D, Helgason A, et al. Genome-wide association study identifies a second pros- tate cancer susceptibility variant at 8q24. Nat Genet 2007;39(5):631-7. Epub 2007 Apr 1.

CFPlus

GO

The English translation of this article, is available at www.cfp.ca. Click on CFPlus to the right of the article or abstract.

*The Gene Messenger on prostate cancer is available at www.cfp.ca. Go to the full text of this article on-line, then click on CFPlus in the menu at the top right- hand side of the page.

GENE MESSENGER

For more information on genetics topics, see www.mtsinai.on.ca/FamMedGen/

Références

Documents relatifs

• Séquençage d’un panel de gènes impliqués dans la réparation homologue dans les cancers de la prostate métastatiques résistants à la castration..

This test measures a protein secreted by prostate cancer cells and accu- rately reflects the amount of cancer present; it can also detect the disease in patients who have no

Les résultats d ’ une étude prospective espagnole, qui a comparé un traitement par radiothérapie externe exclu- sive 3D ou IRMT délivrant une dose totale de 76 Gy en 38 fractions

The complete Gene Messenger—Factor V Leiden by the GenetiKit research team is available on CFPlus.* Past Gene Messenger articles can be accessed online at

The complete Gene Messenger—Preimplantation Genetic Diagnosis by the GenetiKit research team is available on CFPlus.* Past Gene Messenger articles can be

The complete Gene Messenger—Newborn Screening for Sickle Cell Anemia by the GenetiKit research team is available on CFPlus.* Past Gene Messenger articles can

The complete Gene Messenger—Newborn Screening for MCAD Deficiency by the GenetiKit research team is available on CFPlus.* Past Gene Messenger arti- cles can be

The complete Gene Messenger—Hereditary Colorectal Cancer by the GenetiKit research team is available on CFPlus.* Past Gene Messenger articles can be accessed on-line